Youngjo So

Youngjo So

Auto-generated profile, based on publicly available information

Youngjo So

Department of Internal Medicine, College of Korean Medicine, Wonkwang University, Iksan, Republic of Korea

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2025 in Journal of Pharmacopuncture
Verified
Journal Article
Open access
PDF file
Taeseok AhnTaeseok Ahn
Taeseok Ahn
DLDaeook Lee
Daeook Lee
JMJihyun Moon
Jihyun Moon
JKJiwoo Kim
Jiwoo Kim
YSYoungjo So
Youngjo So
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
Taeseok Ahn, Daeook Lee, Jihyun Moon, Jiwoo Kim, Youngjo So, Hyeon-gyu Cho, Sangho Ji, Sangkwan Lee, Myungjin Oh, Cheol-Hyun Kim. J Pharmacopuncture 2025;28:248-54. https://doi.org/10.3831/KPI.2025.28.3.248

1 December 2025 in Journal of Korean Medicine
Verified
Journal Article
Open access
PDF file
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
JKJiwoo Kim
Jiwoo Kim
YSYoungjo So
Youngjo So
HCHyeongyu Cho
Hyeongyu Cho
SJSangho Ji
Sangho Ji
Taeseok AhnTaeseok Ahn
Taeseok Ahn
Introduction: Achilles tendinopathy is a common musculoskeletal condition that significantly impairs gait and overall mobility, ultimately reducing the quality of life. It is characterized by activity-induced pain, swelling, and functional limitations, and is often caused by repetitive microtrauma, increased mechanical load, or reduced vascular supply. Without appropriate treatment, abnormal gait patterns such as medial collapse may occur, leading to long-term biomechanical imbalances. Despite available conservative and surgical options, no clear consensus exists regarding optimal management, and many patients fail to respond adequately. These limitations highlight the need for novel pathophysiology-based therapeutic approaches.Case Presentation: A 49-year-old restaurant worker experienced chronic left heel pain for five years and was diagnosed with chronic Achilles tendinopathy accompanied by calcific tendinitis. Previous treatments, including nine triamcinolone-lidocaine injections and ten platelet-rich plasma sessions, resulted in minimal improvement, and surgical intervention was recommended. She received a total of 12 treatment sessions over a 47-day period. The patient underwent a four-stage ultrasound-guided acupuncture protocol. The protocol included the following: (1) management of paratenonitis, (2) fascial release between the gastrocnemius and soleus muscles using pharmacopuncture, (3) removal of neovascularization via high-volume injection, and (4) periosteal pecking technique (also called dry needling, and referred to as Golmak-Jaktak-beop in traditional Korean medicine) and high-frequency electroacupuncture targeting the Achilles tendon insertion. Post-treatment color Doppler ultrasonography showed reduced intratendinous neovascularization. The patient’s Foot and Ankle Outcome Score (FAOS) subscales demonstrated consistent improvement throughout treatment and at the two-month follow-up.Conclusion: This case suggests that a four-stage ultrasound-guided acupuncture approach may be a potential nonsurgical treatment option for chronic Achilles tendinopathy, especially in patients unresponsive to conventional therapies.

30 June 2025 in Journal of Pharmacopuncture
Verified
Journal Article
Open access
PDF file
JMJihyun Moon
Jihyun Moon
JSJuhwan Song
Juhwan Song
JKJiwoo Kim
Jiwoo Kim
YSYoungjo So
Youngjo So
HCHyeongyu Cho
Hyeongyu Cho
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
Jihyun Moon, Juhwan Song, Jiwoo Kim, Youngjo So, Hyeon-gyu Cho, Sangho Ji, Myungjin Oh, Sangkwan Lee, Taeseok Ahn, Cheol-Hyun Kim. J Pharmacopuncture 2025;28:154-63. https://doi.org/10.3831/KPI.2025.28.2.154

30 June 2026 in Perspectives on Integrative Medicine
Verified
Journal Article
Open access
YSYoungjo So
Youngjo So
JKJiwoo Kim
Jiwoo Kim
HCHyeongyu Cho
Hyeongyu Cho
SJSangho Ji
Sangho Ji
SKSunny Kang
Sunny Kang
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
Background: Central post-stroke pain (CPSP) is a representative central neuropathic pain syndrome caused by lesions of the thalamus or spinothalamic tract. Current diagnostic approaches rely on subjective symptom reporting. Quantitative electroencephalography (qEEG) has gained attention as a noninvasive neurophysiological biomarker with the potential to overcome these limitations.Methods: A total of 50 stroke patients will be recruited at a single center and allocated into either a CPSP group (n = 25) or a control group without central neuropathic pain (n = 25). Using a 2-channel frontal EEG device (Fp1-Fp2), resting-state EEG will be recorded for 5 minutes under both eyes-open and eyes-closed conditions, followed by a 2-minute EEG acquisition during cold stimulation. After artifact removal, frontal asymmetry indices, the delta-to-alpha ratio, and the delta-theta to beta-alpha ratio will be computed. These qEEG parameters will be compared between groups alongside clinical variables including the Neuropathic Pain Symptom Inventory, Patient Health Questionnaire-9, and relevant medical history.Conclusion: This study seeks to identify distinctive qEEG features such as increased slow-wave activity and altered frontal asymmetry in patients with CPSP, thereby providing foundational evidence for establishing qEEG as an objective tool for early diagnosis and standardized assessment of CPSP. Although the single-center design and the limited spatial resolution of the 2-channel EEG system represent inherent constraints, this study protocol is expected to serve as an essential basis for future multi-channel qEEG investigations, machine learningbased analyses, and individualized intervention assessments in CPSP research.

1 January 2025 in Parkinson's Disease
Verified
Journal Article
Open access
Cheol-Hyun KimCheol-Hyun Kim
Cheol-Hyun Kim
Taeseok AhnTaeseok Ahn
Taeseok Ahn
YSYoungjo So
Youngjo So
HCHyeongyu Cho
Hyeongyu Cho
JKJiwoo Kim
Jiwoo Kim
NKNamKwen Kim
NamKwen Kim
Background: Parkinson’s disease (PD) is the second most common neurodegenerative disorder with significant social costs, mainly owing to hospitalization, which is frequently associated with high levodopa equivalent daily dose (LEDD) and polypharmacy rather than neurological symptoms alone. Integrative treatment combining Western and Korean medicine may help control these factors and reduce the need for hospitalization. We investigated the potential impact of integrative treatment on LEDD and polypharmacy in patients with PD > 5 years postdiagnosis. Methods: Fifteen patients with PD (KCD code G20), diagnosed > 5 years earlier, who received integrative treatment at Gwangju Korean Medicine Hospital, Wonkwang University, from April 1, 2022, to July 30, 2024, were enrolled. A retrospective chart review was conducted to collect demographic and clinical data, including LEDD, medication count, and treatment details. Summary statistics were presented as median (IQR) and mean ± SD. Results: In the integrative treatment cohort, the prevalence of both LEDD and polypharmacy was lower than that in studies involving conventional treatment alone. The mean LEDD was 321.71 (median, 200.0) mg, while only two patients exceeded the LEDD threshold of 300 mg, which was associated with motor complications. Polypharmacy was observed in 13.3% of patients and hyperpolypharmacy in 6.7%, representing lower proportions compared with previous reports on conventional treatments. Representative cases highlighted symptom improvement and a reduced need for medication with integrative approaches, particularly acupuncture and herbal medicine. Conclusion: These findings suggest that integrative treatment may contribute to lowering LEDD and medication counts in patients with PD, which could potentially reduce hospitalization rates and the associated social costs. Further prospective studies comparing the integrative and nonintegrative treatment groups are needed to clarify these findings and evaluate the role of integrative treatment in the long‐term management of PD.